Be in the know. 7 key reads for Thursday…

  1. Gilead Sciences (GILD) Initiates Two Phase 3 Studies of Remdesivir for Treatment of COVID-19 (Street Insider)
  2. Wait for these signals to buy coronavirus-battered stocks, says BNY Mellon strategist (MarketWatch)
  3. The US-China trade war unintentionally prepared companies for coronavirus (Yahoo Finance)
  4. Wall Street and Atlanta Federal Reserve don’t agree on GDP (New York Post)
  5. TikTok Marketers Chase Billions of Views in Uncharted Terrain (Bloomberg)
  6. Big Oil Price Jump Predicted By Report If Fracking Ends In US (Benzinga)
  7. As China’s Economy Suffers, Xi Faces Pressure to Lift Virus Restrictions (Wall Street Journal)